Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity	Cognition Disorders, Cognitive Dysfunction, Nutritional and Metabolic Diseases, Parkinson disease, Pathological Conditions, Signs and Symptoms, Prodromal Stage, Prodromal Symptoms, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, metabolic disease, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, proteostasis deficiencies, psychiatric disorder, synucleinopathy	Recruiting	Not applicable	2026-01-16		NCT07324330

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
IJsfontein B.V., Netherlands	3
Medical University Innsbruck	69
Parkinson Stiftung	2
Radboud University Medical Center	216
Synaptikon GmbH	1
University Hospital, Bonn	44

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital of Bonn	Bonn	Germany	1